Authors: Chen Yao, Cheng Gangwei DOI: 10.3760/cma.j.cn115989-20201222-00857 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 885-891. Abstract [View PDF] [Read Full Text] Objective To compare the efficacy of phacoemulsification+ goniosynechialysis (Phaco-GSL) and Phaco alone for chronic primary angle-closure glaucoma (CPACG) patients with peripheral anterior […]
Month: October 2021
Association between the function of Schlemm canal and outcome following selective laser trabeculoplasty for primary open-angle glaucoma
Authors: Ran Guangyao, Sun Anqi, Li Mu, Xie Wei, Zhang Hong DOI: 10.3760/cma.j.cn115989-20190716-00314 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 892-897. Abstract [View PDF] [Read Full Text] Objective To investigate the relationship between the function of Schlemm canal and the efficacy of selective […]
Analysis of life quality of primary angle-closure glaucoma patients and its influencing factors in Baotou region, Inner Mongolia
Authors: Li Liang, Su Yufang, Zhang Hui, Wang Hui, Liu Yingru, Cao Kai, Qiao Chunyan DOI: 10.3760/cma.j.cn115989-20200723-00522 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 898-905. Abstract [View PDF] [Read Full Text] Objective To investigate vision-related quality of life, anxiety and depression in patients […]
Highlights of Terminology and Guidelines for Glaucoma (5th edition): an interpretation
Authors: Chen Junyi, Sun Xinghuai DOI: 10.3760/cma.j.cn115989-20210903-00494 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 906-909. Abstract [View PDF] [Read Full Text] With the accelerated development of aging society, the incidence of glaucoma is increasing in recent years.Glaucoma is a primary cause of irreversible […]
Research on real-world study of tafluprost in glaucoma and ocular hypertension
Authors: Zhang Yue, Sun Yunxiao, Wang Ningli DOI: 10.3760/cma.j.cn115989-20210418-00257 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 910-914. Abstract [View PDF] [Read Full Text] Medication treatment is the most common measure for lowering intraocular pressure in glaucoma, and prostaglandin analogues have been unanimously recommended […]
Physiological role and neuroprotective effects of somatostatin in retina
Authors: Zhang Yi, Sun Xinghuai, Wang Zhongfeng DOI: 10.3760/cma.j.cn115989-20191112-00492 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 915-918. Abstract [View PDF] [Read Full Text] Somatostatin, also called somatotropin release-inhibiting factor (SRIF), is a kind of neurotransmitter, neuromodulator and neurotrophic factor, which participates in a […]
Role of lncRNA in the proliferation mechanism of Tenon fibroblasts
Authors: Cheng Yue, Wang Feng, Su Ying DOI: 10.3760/cma.j.cn115989-20190627-00279 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 919-922. Abstract [View PDF] [Read Full Text] At present, the mechanism of scar formation in filtering area after glaucoma filtering surgery has not been fully understood.It is […]
Research progress of autophagy in the pathogenesis of glaucoma
Authors: Xu Yaohan, Han Wei DOI: 10.3760/cma.j.cn115989-20210712-00407 Published 2021-10-10 Cite asChin J Exp Ophthalmol, 2021, 39(10): 923-928. Abstract [View PDF] [Read Full Text] Glaucoma, a neurodegenerative disease characterized by progressive death of retinal ganglion cells (RGCs) and chronic axonal degeneration, is often associated with elevated […]